Leukotaxis and leukotactic disorders. A review.
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001424:Bacterial Infections / Q000276:immunology; D001426:Bacterial Proteins / Q000494:pharmacology; D001491:Basophils / Q000276:immunology; D002609:Chediak-Higashi Syndrome / Q000276:immunology; D002633:Chemotaxis; D003165:Complement System Proteins; D004789:Enzyme Activation; D004804:Eosinophils / Q000276:immunology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007610:Kallikreins / Q000494:pharmacology; D007962:Leukocytes / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D008222:Lymphokines / Q000494:pharmacology; D008851:Micropore Filters; D009000:Monocytes / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D010455:Peptides / Q000494:pharmacology; D010958:Plasminogen; D014780:Viruses / Q000201:enzymology
D000893:Anti-Inflammatory Agents; D001426:Bacterial Proteins; D008222:Lymphokines; D010455:Peptides; D010958:Plasminogen; D003165:Complement System Proteins; D007610:Kallikreins